Suchergebnisse - "Shah, Rashmi R"

PubPharm (115)

1

Chloroquine and hydroxychloroquine for COVID-19 : Perspectives on their failure in repurposing

enthalten in: Journal of clinical pharmacy and therapeutics | 2021

von Shah, R.

2

Genotype-guided warfarin therapy : Still of only questionable value two decades on

enthalten in: Journal of clinical pharmacy and therapeutics | 2020

von Shah, R.

3

Safety of Novel Targeted Therapies in Oncology

enthalten in: Drug safety | 2019

von Shah, R. | Curigliano, G.

4

Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology

enthalten in: Drug safety | 2019

von Shah, R.

5

Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology

enthalten in: Drug safety | 2019

von Shah, R. | Shah, D.

6

Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology

enthalten in: Drug safety | 2019

von Curigliano, G. | Shah, R.

7

Repurposing old drugs in oncology : Opportunities with clinical and regulatory challenges ahead

enthalten in: Journal of clinical pharmacy and therapeutics | 2019

von Shah, R. | Stonier, P.

8

Metamizole (dipyrone)-induced agranulocytosis : Does the risk vary according to ethnicity?

enthalten in: Journal of clinical pharmacy and therapeutics | 2019

von Shah, R.

9

Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology

enthalten in: Medical toxicology | 2019

von Curigliano, G. | Shah, R.

10

Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology

enthalten in: Medical toxicology | 2019

von Shah, R.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]